BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26657051)

  • 1. Clarification of vaccines: An overview of filter based technology trends and best practices.
    Besnard L; Fabre V; Fettig M; Gousseinov E; Kawakami Y; Laroudie N; Scanlan C; Pattnaik P
    Biotechnol Adv; 2016; 34(1):1-13. PubMed ID: 26657051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process cost and facility considerations in the selection of primary cell culture clarification technology.
    Felo M; Christensen B; Higgins J
    Biotechnol Prog; 2013; 29(5):1239-45. PubMed ID: 23847160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in primary recovery: centrifugation and membrane technology.
    Roush DJ; Lu Y
    Biotechnol Prog; 2008; 24(3):488-95. PubMed ID: 18410157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane separations in biotechnology.
    van Reis R; Zydney A
    Curr Opin Biotechnol; 2001 Apr; 12(2):208-11. PubMed ID: 11287239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manufacturing of Proteins and Antibodies: Chapter Downstream Processing Technologies.
    Turner R; Joseph A; Titchener-Hooker N; Bender J
    Adv Biochem Eng Biotechnol; 2018; 165():95-114. PubMed ID: 28776064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarification of recombinant proteins from high cell density mammalian cell culture systems using new improved depth filters.
    Singh N; Pizzelli K; Romero JK; Chrostowski J; Evangelist G; Hamzik J; Soice N; Cheng KS
    Biotechnol Bioeng; 2013 Jul; 110(7):1964-72. PubMed ID: 23334838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid DNA primary recovery from E. coli lysates by depth bed microfiltration.
    Padilla-Zamudio A; Guerrero-Germán P; Tejeda-Mansir A
    Bioprocess Biosyst Eng; 2015 Jun; 38(6):1091-6. PubMed ID: 25579880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hollow fiber tangential flow filtration for the recovery and concentration of HIV virus-like particles produced in insect cells.
    Negrete A; Pai A; Shiloach J
    J Virol Methods; 2014 Jan; 195():240-6. PubMed ID: 24157258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different options for harvest of a therapeutic protein product from high cell density yeast fermentation broth.
    Wang A; Lewus R; Rathore AS
    Biotechnol Bioeng; 2006 May; 94(1):91-104. PubMed ID: 16440354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downstream processing in the biotechnology industry.
    Kalyanpur M
    Mol Biotechnol; 2002 Sep; 22(1):87-98. PubMed ID: 12353915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine process technology.
    Josefsberg JO; Buckland B
    Biotechnol Bioeng; 2012 Jun; 109(6):1443-60. PubMed ID: 22407777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An effective, simple and low-cost pretreatment for culture clarification in tetanus toxoid production.
    Avila L; Cascone O; Biscoglio M; Fingermann M
    Prep Biochem Biotechnol; 2018; 48(9):808-814. PubMed ID: 30265189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra scale-down approaches to study the centrifugal harvest for viral vaccine production.
    Melinek BJ; Dessoy S; Wright B; Bracewell DG; Mukhopadhyay TK
    Biotechnol Bioeng; 2018 May; 115(5):1226-1238. PubMed ID: 29315484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate.
    Bakhshizadeh Gashti A; Chahal PS; Gaillet B; Garnier A
    Vaccine; 2023 Mar; 41(13):2198-2207. PubMed ID: 36842887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-stage chromatographic clarification of Chinese Hamster Ovary cell harvest reduces cost of protein production.
    O'Mara B; Singh NK; Menendez A; Tipton B; Vail A; Voloshin A; Buechler Y; Anderson SM
    Biotechnol Prog; 2023 Mar; 39(2):e3323. PubMed ID: 36598038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstream process design for Gag HIV-1 based virus-like particles.
    Lorenzo E; Miranda L; Gòdia F; Cervera L
    Biotechnol Bioeng; 2023 Sep; 120(9):2672-2684. PubMed ID: 37148527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large scale purification process for recombinant NS1-OspA as a candidate vaccine for Lyme disease.
    Caldwell SR; Varghese J; Puri NK
    Bioseparation; 1996 Apr; 6(2):115-23. PubMed ID: 8818266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-based techniques for the separation and purification of proteins: an overview.
    Saxena A; Tripathi BP; Kumar M; Shahi VK
    Adv Colloid Interface Sci; 2009 Jan; 145(1-2):1-22. PubMed ID: 18774120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flocculation increases the efficacy of depth filtration during the downstream processing of recombinant pharmaceutical proteins produced in tobacco.
    Buyel JF; Fischer R
    Plant Biotechnol J; 2014 Feb; 12(2):240-52. PubMed ID: 24165151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A methodological approach to scaling up fermentation and primary recovery processes to the manufacturing scale for vaccine production.
    Lee TS
    Vaccine; 2009 Oct; 27(46):6439-43. PubMed ID: 19577635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.